

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine catabolic process (GO:0006554) | 5.75851247 |
| 2 | lysine metabolic process (GO:0006553) | 5.75851247 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.61956911 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.61956911 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.56915717 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.56915717 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.30548494 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.08081036 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.00396519 |
| 10 | 2-oxoglutarate metabolic process (GO:0006103) | 4.95587680 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.94472428 |
| 12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.94139643 |
| 13 | kynurenine metabolic process (GO:0070189) | 4.90163020 |
| 14 | fatty acid transmembrane transport (GO:1902001) | 4.80757201 |
| 15 | carnitine shuttle (GO:0006853) | 4.74837700 |
| 16 | proline biosynthetic process (GO:0006561) | 4.72705333 |
| 17 | cysteine metabolic process (GO:0006534) | 4.69011144 |
| 18 | amino-acid betaine metabolic process (GO:0006577) | 4.64390066 |
| 19 | fatty acid beta-oxidation (GO:0006635) | 4.64004349 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 4.62337758 |
| 21 | valine metabolic process (GO:0006573) | 4.56829401 |
| 22 | urea metabolic process (GO:0019627) | 4.56590973 |
| 23 | urea cycle (GO:0000050) | 4.56590973 |
| 24 | acetyl-CoA metabolic process (GO:0006084) | 4.54795061 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.48750893 |
| 26 | serine family amino acid catabolic process (GO:0009071) | 4.45012280 |
| 27 | aspartate family amino acid catabolic process (GO:0009068) | 4.42799924 |
| 28 | tryptophan catabolic process (GO:0006569) | 4.41636160 |
| 29 | indole-containing compound catabolic process (GO:0042436) | 4.41636160 |
| 30 | indolalkylamine catabolic process (GO:0046218) | 4.41636160 |
| 31 | bile acid biosynthetic process (GO:0006699) | 4.39699222 |
| 32 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.39185937 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.32752351 |
| 34 | Golgi transport vesicle coating (GO:0048200) | 4.29688797 |
| 35 | COPI coating of Golgi vesicle (GO:0048205) | 4.29688797 |
| 36 | fatty acid oxidation (GO:0019395) | 4.28538198 |
| 37 | complement activation, alternative pathway (GO:0006957) | 4.24278778 |
| 38 | lipid oxidation (GO:0034440) | 4.19245422 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.16931996 |
| 40 | tryptophan metabolic process (GO:0006568) | 4.14842795 |
| 41 | fatty acid catabolic process (GO:0009062) | 4.13398030 |
| 42 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.12626262 |
| 43 | negative regulation of fibrinolysis (GO:0051918) | 4.11539003 |
| 44 | desmosome organization (GO:0002934) | 4.10440513 |
| 45 | carnitine metabolic process (GO:0009437) | 4.06290836 |
| 46 | regulation of sequestering of triglyceride (GO:0010889) | 4.05631008 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 4.05111618 |
| 48 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.04469228 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.04454630 |
| 50 | short-chain fatty acid metabolic process (GO:0046459) | 4.02602704 |
| 51 | regulation of protein activation cascade (GO:2000257) | 4.01991551 |
| 52 | tricarboxylic acid metabolic process (GO:0072350) | 4.01913288 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.01063561 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.01063561 |
| 55 | tricarboxylic acid cycle (GO:0006099) | 4.00024552 |
| 56 | protein carboxylation (GO:0018214) | 3.99494241 |
| 57 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.99494241 |
| 58 | glycine metabolic process (GO:0006544) | 3.98323183 |
| 59 | cell-substrate adherens junction assembly (GO:0007045) | 3.95459846 |
| 60 | focal adhesion assembly (GO:0048041) | 3.95459846 |
| 61 | positive regulation of fatty acid oxidation (GO:0046321) | 3.93774117 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 3.93110676 |
| 63 | biotin metabolic process (GO:0006768) | 3.92946743 |
| 64 | regulation of fatty acid oxidation (GO:0046320) | 3.92053409 |
| 65 | oxaloacetate metabolic process (GO:0006107) | 3.90931962 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 3.90601554 |
| 67 | high-density lipoprotein particle remodeling (GO:0034375) | 3.88065469 |
| 68 | adherens junction assembly (GO:0034333) | 3.86845926 |
| 69 | phospholipid homeostasis (GO:0055091) | 3.85809721 |
| 70 | negative regulation of cell size (GO:0045792) | 3.84726641 |
| 71 | ethanol oxidation (GO:0006069) | 3.84056986 |
| 72 | regulation of translational fidelity (GO:0006450) | 3.83546468 |
| 73 | regulation of cholesterol homeostasis (GO:2000188) | 3.82539562 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 3.82404936 |
| 75 | apoptotic process involved in morphogenesis (GO:0060561) | 3.79924692 |
| 76 | carnitine transmembrane transport (GO:1902603) | 3.79498414 |
| 77 | regulation of complement activation (GO:0030449) | 3.78145038 |
| 78 | bile acid metabolic process (GO:0008206) | 3.77477612 |
| 79 | positive regulation of lipid catabolic process (GO:0050996) | 3.77218603 |
| 80 | carnitine transport (GO:0015879) | 3.76298354 |
| 81 | amino-acid betaine transport (GO:0015838) | 3.76298354 |
| 82 | regulation of fibrinolysis (GO:0051917) | 3.75282461 |
| 83 | proline metabolic process (GO:0006560) | 3.74573216 |
| 84 | glutamate metabolic process (GO:0006536) | 3.73792962 |
| 85 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.71720440 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 3.71577114 |
| 87 | serine family amino acid metabolic process (GO:0009069) | 3.71535626 |
| 88 | branched-chain amino acid catabolic process (GO:0009083) | 3.69935348 |
| 89 | branched-chain amino acid metabolic process (GO:0009081) | 3.66456028 |
| 90 | activation of Rac GTPase activity (GO:0032863) | 3.63195557 |
| 91 | organic acid catabolic process (GO:0016054) | 3.62476629 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.62476629 |
| 93 | low-density lipoprotein particle clearance (GO:0034383) | 3.60584471 |
| 94 | negative regulation of sterol transport (GO:0032372) | 3.60080861 |
| 95 | negative regulation of cholesterol transport (GO:0032375) | 3.60080861 |
| 96 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.57574825 |
| 97 | mitotic chromosome condensation (GO:0007076) | 3.56611751 |
| 98 | aromatic amino acid family metabolic process (GO:0009072) | 3.56565418 |
| 99 | fatty acid homeostasis (GO:0055089) | 3.54431002 |
| 100 | protein-lipid complex remodeling (GO:0034368) | 3.54061302 |
| 101 | macromolecular complex remodeling (GO:0034367) | 3.54061302 |
| 102 | plasma lipoprotein particle remodeling (GO:0034369) | 3.54061302 |
| 103 | DNA unwinding involved in DNA replication (GO:0006268) | 3.53416784 |
| 104 | NADH metabolic process (GO:0006734) | 3.51915385 |
| 105 | reverse cholesterol transport (GO:0043691) | 3.49826540 |
| 106 | cell-substrate junction assembly (GO:0007044) | 3.48751390 |
| 107 | ketone body metabolic process (GO:1902224) | 3.48122665 |
| 108 | serine family amino acid biosynthetic process (GO:0009070) | 3.44165629 |
| 109 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.44007586 |
| 110 | coenzyme catabolic process (GO:0009109) | 3.43640163 |
| 111 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.42026356 |
| 112 | tyrosine metabolic process (GO:0006570) | 3.40046362 |
| 113 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.35908035 |
| 114 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.32896137 |
| 115 | succinate metabolic process (GO:0006105) | 3.28179272 |
| 116 | protein localization to endosome (GO:0036010) | 3.27121977 |
| 117 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.27105385 |
| 118 | regulation of cholesterol metabolic process (GO:0090181) | 3.26462896 |
| 119 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.25714050 |
| 120 | regulation of cholesterol esterification (GO:0010872) | 3.25444837 |
| 121 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.24328505 |
| 122 | quaternary ammonium group transport (GO:0015697) | 3.23879923 |
| 123 | epithelial cell-cell adhesion (GO:0090136) | 3.20870099 |
| 124 | maternal placenta development (GO:0001893) | 3.17305695 |
| 125 | hemidesmosome assembly (GO:0031581) | 3.17054414 |
| 126 | regulation of early endosome to late endosome transport (GO:2000641) | 3.13177910 |
| 127 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.12206996 |
| 128 | pentose-phosphate shunt (GO:0006098) | 3.04341606 |
| 129 | nuclear pore complex assembly (GO:0051292) | 3.00965080 |
| 130 | regulation of translational termination (GO:0006449) | 3.00049071 |
| 131 | glucose 6-phosphate metabolic process (GO:0051156) | 2.99006821 |
| 132 | basement membrane organization (GO:0071711) | 2.97671987 |
| 133 | gluconeogenesis (GO:0006094) | 2.96764436 |
| 134 | glucose catabolic process (GO:0006007) | 2.93216943 |
| 135 | monosaccharide biosynthetic process (GO:0046364) | 2.89691404 |
| 136 | cellular protein complex localization (GO:0034629) | 2.86580592 |
| 137 | creatine metabolic process (GO:0006600) | 2.86557898 |
| 138 | negative regulation of fatty acid transport (GO:2000192) | 2.85524696 |
| 139 | hexose biosynthetic process (GO:0019319) | 2.84073676 |
| 140 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.83831649 |
| 141 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.79358374 |
| 142 | protein retention in ER lumen (GO:0006621) | 2.77701822 |
| 143 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.77214692 |
| 144 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.75771584 |
| 145 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.75217466 |
| 146 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.71843609 |
| 147 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.69960359 |
| 148 | protein complex localization (GO:0031503) | 2.68974814 |
| 149 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.63886333 |
| 150 | folic acid metabolic process (GO:0046655) | 2.63698281 |
| 151 | NADPH regeneration (GO:0006740) | 2.59080286 |
| 152 | regulation of RNA export from nucleus (GO:0046831) | 2.58497270 |
| 153 | mRNA stabilization (GO:0048255) | 2.57540733 |
| 154 | RNA stabilization (GO:0043489) | 2.57540733 |
| 155 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.55593382 |
| 156 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.53637181 |
| 157 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.53060961 |
| 158 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.53057821 |
| 159 | semaphorin-plexin signaling pathway (GO:0071526) | 2.52783999 |
| 160 | protein localization to microtubule (GO:0035372) | 2.51591535 |
| 161 | negative regulation of viral release from host cell (GO:1902187) | 2.51547449 |
| 162 | mannose metabolic process (GO:0006013) | 2.51177422 |
| 163 | atrioventricular valve morphogenesis (GO:0003181) | 2.50723551 |
| 164 | embryonic process involved in female pregnancy (GO:0060136) | 2.48312411 |
| 165 | positive regulation of nuclease activity (GO:0032075) | 2.47181922 |
| 166 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.46762813 |
| 167 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.46582873 |
| 168 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.46019741 |
| 169 | mitochondrial fusion (GO:0008053) | 2.44847809 |
| 170 | glycolytic process (GO:0006096) | 2.43822271 |
| 171 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.43636169 |
| 172 | activation of MAPKKK activity (GO:0000185) | 2.42399111 |
| 173 | regulation of water loss via skin (GO:0033561) | 2.41414136 |
| 174 | pinocytosis (GO:0006907) | 2.40854471 |
| 175 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.40599169 |
| 176 | 4-hydroxyproline metabolic process (GO:0019471) | 2.39403374 |
| 177 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.38173347 |
| 178 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.37409408 |
| 179 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.33120316 |
| 180 | nuclear pore organization (GO:0006999) | 2.32331338 |
| 181 | peptidyl-lysine dimethylation (GO:0018027) | 2.31495391 |
| 182 | snRNA metabolic process (GO:0016073) | 2.31378423 |
| 183 | regulation of histone H3-K27 methylation (GO:0061085) | 2.30638642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.42920004 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.53678944 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.59281539 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.00442447 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.22026471 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.07686632 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.01572680 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.73289403 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.69080233 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.30695264 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.12082850 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.62506458 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.42690274 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.35617019 |
| 15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.02751692 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91951827 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.89126678 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.87101708 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.86934567 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.84995087 |
| 21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.80430194 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.78096124 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.75436513 |
| 24 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.75428925 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.72297213 |
| 26 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.65579381 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58644518 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57625347 |
| 29 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.56923658 |
| 30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.48838551 |
| 31 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.46592445 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45523039 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.45186854 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44877858 |
| 35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.44379955 |
| 36 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.43099251 |
| 37 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.43099251 |
| 38 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.42351325 |
| 39 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40759014 |
| 40 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.40121536 |
| 41 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.39787125 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38294802 |
| 43 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38092158 |
| 44 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36567364 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36246551 |
| 46 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.36035535 |
| 47 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35641536 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.34797851 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.34668677 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33844294 |
| 51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33575364 |
| 52 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.33471299 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32680321 |
| 54 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32380636 |
| 55 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.30178391 |
| 56 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27822832 |
| 57 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27090635 |
| 58 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.24099799 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23292662 |
| 60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.23259146 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22993659 |
| 62 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.21455249 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18242149 |
| 64 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14405026 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13136712 |
| 66 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.11955541 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10173027 |
| 68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09999820 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09799904 |
| 70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09025158 |
| 71 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08881643 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07791256 |
| 73 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07349576 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06488253 |
| 75 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.06439919 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.06121416 |
| 77 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.06065262 |
| 78 | MAF_26560356_Chip-Seq_TH1_Human | 1.05472035 |
| 79 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05191600 |
| 80 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.03954414 |
| 81 | MYC_22102868_ChIP-Seq_BL_Human | 1.03939177 |
| 82 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02403063 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01446509 |
| 84 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01077312 |
| 85 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.98136469 |
| 86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97780411 |
| 87 | MAF_26560356_Chip-Seq_TH2_Human | 0.97153119 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95671012 |
| 89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95446730 |
| 90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94593156 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94089534 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91126470 |
| 93 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90989746 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90385356 |
| 95 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.87883663 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 0.87609399 |
| 97 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86566901 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86559782 |
| 99 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86256047 |
| 100 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85946360 |
| 101 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84785864 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83330716 |
| 103 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82645485 |
| 104 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.81693412 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.81651473 |
| 106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.80922323 |
| 107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.79398921 |
| 108 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79290743 |
| 109 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78991903 |
| 110 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78642767 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78116244 |
| 112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77546876 |
| 113 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.77300044 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76867881 |
| 115 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76218560 |
| 116 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.75855435 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75755858 |
| 118 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.75698253 |
| 119 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74337954 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74035373 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73910290 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72886146 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72306207 |
| 124 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.71288377 |
| 125 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.70985556 |
| 126 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69244180 |
| 127 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.68901504 |
| 128 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.68370198 |
| 129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67301593 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65706003 |
| 131 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.65532108 |
| 132 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.65489039 |
| 133 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.64224151 |
| 134 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.64138017 |
| 135 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.63593974 |
| 136 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.63249778 |
| 137 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.63144310 |
| 138 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.62726420 |
| 139 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.62244499 |
| 140 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.62171643 |
| 141 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.62119743 |
| 142 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.61208735 |
| 143 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.61135028 |
| 144 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61041398 |
| 145 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.60764731 |
| 146 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.60752720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.09409140 |
| 2 | MP0005360_urolithiasis | 5.89882244 |
| 3 | MP0005365_abnormal_bile_salt | 4.82310605 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.78488374 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.83599379 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.49432115 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.45979358 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.35425772 |
| 9 | MP0003252_abnormal_bile_duct | 3.19395452 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.15868527 |
| 11 | MP0005670_abnormal_white_adipose | 2.75684998 |
| 12 | MP0005076_abnormal_cell_differentiation | 2.72826843 |
| 13 | MP0009840_abnormal_foam_cell | 2.64597731 |
| 14 | MP0005332_abnormal_amino_acid | 2.49949509 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.49587054 |
| 16 | MP0004130_abnormal_muscle_cell | 2.49293370 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.42162609 |
| 18 | MP0003646_muscle_fatigue | 2.31729523 |
| 19 | MP0005083_abnormal_biliary_tract | 2.30554590 |
| 20 | MP0005666_abnormal_adipose_tissue | 2.15942450 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.14699167 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.05033438 |
| 23 | MP0004084_abnormal_cardiac_muscle | 2.03467453 |
| 24 | MP0003195_calcinosis | 2.03340405 |
| 25 | MP0000609_abnormal_liver_physiology | 2.03126343 |
| 26 | MP0004858_abnormal_nervous_system | 2.02751633 |
| 27 | MP0001849_ear_inflammation | 2.00450745 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.96526076 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.95770005 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.94050017 |
| 31 | MP0005330_cardiomyopathy | 1.85036806 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.84797703 |
| 33 | MP0000751_myopathy | 1.80430940 |
| 34 | MP0005409_darkened_coat_color | 1.77853388 |
| 35 | MP0005501_abnormal_skin_physiology | 1.75637592 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.70010179 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.63406983 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.57396063 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.57135617 |
| 40 | MP0004215_abnormal_myocardial_fiber | 1.56054994 |
| 41 | MP0001730_embryonic_growth_arrest | 1.55771366 |
| 42 | MP0000537_abnormal_urethra_morphology | 1.55009089 |
| 43 | MP0000733_abnormal_muscle_development | 1.51766000 |
| 44 | MP0004036_abnormal_muscle_relaxation | 1.51373540 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.48544603 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48081337 |
| 47 | MP0008260_abnormal_autophagy | 1.47853090 |
| 48 | MP0004087_abnormal_muscle_fiber | 1.46937937 |
| 49 | MP0003111_abnormal_nucleus_morphology | 1.46791039 |
| 50 | MP0002971_abnormal_brown_adipose | 1.46549668 |
| 51 | MP0002269_muscular_atrophy | 1.43582603 |
| 52 | MP0001348_abnormal_lacrimal_gland | 1.43480813 |
| 53 | MP0005375_adipose_tissue_phenotype | 1.40110825 |
| 54 | MP0000579_abnormal_nail_morphology | 1.35745764 |
| 55 | MP0004510_myositis | 1.34989865 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.33855296 |
| 57 | MP0002249_abnormal_larynx_morphology | 1.30281426 |
| 58 | MP0000749_muscle_degeneration | 1.28348516 |
| 59 | MP0010630_abnormal_cardiac_muscle | 1.28145236 |
| 60 | MP0004264_abnormal_extraembryonic_tissu | 1.28020940 |
| 61 | MP0008775_abnormal_heart_ventricle | 1.27287774 |
| 62 | MP0002089_abnormal_postnatal_growth/wei | 1.26612901 |
| 63 | MP0003693_abnormal_embryo_hatching | 1.25908872 |
| 64 | MP0002060_abnormal_skin_morphology | 1.24849186 |
| 65 | MP0000566_synostosis | 1.24716649 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 1.24605980 |
| 67 | MP0003091_abnormal_cell_migration | 1.21355281 |
| 68 | MP0001544_abnormal_cardiovascular_syste | 1.20145193 |
| 69 | MP0005385_cardiovascular_system_phenoty | 1.20145193 |
| 70 | MP0000467_abnormal_esophagus_morphology | 1.18849243 |
| 71 | MP0006138_congestive_heart_failure | 1.14992578 |
| 72 | MP0005451_abnormal_body_composition | 1.13665415 |
| 73 | MP0001216_abnormal_epidermal_layer | 1.11997820 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11901101 |
| 75 | MP0001764_abnormal_homeostasis | 1.10595209 |
| 76 | MP0000598_abnormal_liver_morphology | 1.10541438 |
| 77 | MP0005623_abnormal_meninges_morphology | 1.09492167 |
| 78 | MP0002972_abnormal_cardiac_muscle | 1.08609822 |
| 79 | MP0004947_skin_inflammation | 1.07142906 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 1.06460309 |
| 81 | MP0005334_abnormal_fat_pad | 1.06025940 |
| 82 | MP0001873_stomach_inflammation | 1.05639936 |
| 83 | MP0004957_abnormal_blastocyst_morpholog | 1.04122721 |
| 84 | MP0000750_abnormal_muscle_regeneration | 1.01717109 |
| 85 | MP0000858_altered_metastatic_potential | 1.01367202 |
| 86 | MP0000747_muscle_weakness | 1.00939080 |
| 87 | MP0003186_abnormal_redox_activity | 0.99352287 |
| 88 | MP0005620_abnormal_muscle_contractility | 0.98756569 |
| 89 | MP0005257_abnormal_intraocular_pressure | 0.98332677 |
| 90 | MP0000350_abnormal_cell_proliferation | 0.96833762 |
| 91 | MP0003868_abnormal_feces_composition | 0.96735375 |
| 92 | MP0002098_abnormal_vibrissa_morphology | 0.96690073 |
| 93 | MP0005266_abnormal_metabolism | 0.96281976 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.95746119 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.94705365 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.94376402 |
| 97 | MP0003984_embryonic_growth_retardation | 0.94274917 |
| 98 | MP0004272_abnormal_basement_membrane | 0.93847212 |
| 99 | MP0002080_prenatal_lethality | 0.93736670 |
| 100 | MP0009115_abnormal_fat_cell | 0.93152715 |
| 101 | MP0010368_abnormal_lymphatic_system | 0.93045363 |
| 102 | MP0009333_abnormal_splenocyte_physiolog | 0.92447146 |
| 103 | MP0002970_abnormal_white_adipose | 0.91552541 |
| 104 | MP0005535_abnormal_body_temperature | 0.91246843 |
| 105 | MP0005023_abnormal_wound_healing | 0.90134725 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.90007157 |
| 107 | MP0001672_abnormal_embryogenesis/_devel | 0.89529091 |
| 108 | MP0005380_embryogenesis_phenotype | 0.89529091 |
| 109 | MP0003077_abnormal_cell_cycle | 0.88415225 |
| 110 | MP0010094_abnormal_chromosome_stability | 0.88403990 |
| 111 | MP0002396_abnormal_hematopoietic_system | 0.88170641 |
| 112 | MP0002088_abnormal_embryonic_growth/wei | 0.86578215 |
| 113 | MP0009931_abnormal_skin_appearance | 0.85530305 |
| 114 | MP0002086_abnormal_extraembryonic_tissu | 0.84972879 |
| 115 | MP0003137_abnormal_impulse_conducting | 0.84337696 |
| 116 | MP0005621_abnormal_cell_physiology | 0.83581491 |
| 117 | MP0000762_abnormal_tongue_morphology | 0.82809256 |
| 118 | MP0009278_abnormal_bone_marrow | 0.82444743 |
| 119 | MP0003329_amyloid_beta_deposits | 0.80111914 |
| 120 | MP0001756_abnormal_urination | 0.79377008 |
| 121 | MP0000003_abnormal_adipose_tissue | 0.79153355 |
| 122 | MP0002106_abnormal_muscle_physiology | 0.78952516 |
| 123 | MP0009763_increased_sensitivity_to | 0.78272563 |
| 124 | MP0005448_abnormal_energy_balance | 0.77741397 |
| 125 | MP0000604_amyloidosis | 0.76050937 |
| 126 | MP0001661_extended_life_span | 0.75885552 |
| 127 | MP0000759_abnormal_skeletal_muscle | 0.75864624 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.75639838 |
| 129 | MP0003300_gastrointestinal_ulcer | 0.75113816 |
| 130 | MP0004233_abnormal_muscle_weight | 0.74853670 |
| 131 | MP0002166_altered_tumor_susceptibility | 0.74554410 |
| 132 | MP0000377_abnormal_hair_follicle | 0.73665582 |
| 133 | MP0001915_intracranial_hemorrhage | 0.73520719 |
| 134 | MP0009642_abnormal_blood_homeostasis | 0.73280473 |
| 135 | MP0005647_abnormal_sex_gland | 0.73142409 |
| 136 | MP0010030_abnormal_orbit_morphology | 0.72725350 |
| 137 | MP0004808_abnormal_hematopoietic_stem | 0.71462491 |
| 138 | MP0004381_abnormal_hair_follicle | 0.70781835 |
| 139 | MP0001346_abnormal_lacrimal_gland | 0.70309108 |
| 140 | MP0005636_abnormal_mineral_homeostasis | 0.69811352 |
| 141 | MP0000490_abnormal_crypts_of | 0.69400618 |
| 142 | MP0004043_abnormal_pH_regulation | 0.68093952 |
| 143 | MP0005376_homeostasis/metabolism_phenot | 0.68024157 |
| 144 | MP0009672_abnormal_birth_weight | 0.66543970 |
| 145 | MP0008438_abnormal_cutaneous_collagen | 0.65437406 |
| 146 | MP0002254_reproductive_system_inflammat | 0.64467867 |
| 147 | MP0002332_abnormal_exercise_endurance | 0.61589881 |
| 148 | MP0004085_abnormal_heartbeat | 0.60363575 |
| 149 | MP0005369_muscle_phenotype | 0.59742002 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.54366222 |
| 151 | MP0000266_abnormal_heart_morphology | 0.53368314 |
| 152 | MP0008469_abnormal_protein_level | 0.53347099 |
| 153 | MP0003828_pulmonary_edema | 0.53281344 |
| 154 | MP0002136_abnormal_kidney_physiology | 0.51410443 |
| 155 | MP0003953_abnormal_hormone_level | 0.49150655 |
| 156 | MP0002128_abnormal_blood_circulation | 0.49075655 |
| 157 | MP0000013_abnormal_adipose_tissue | 0.48594608 |
| 158 | MP0002127_abnormal_cardiovascular_syste | 0.47928983 |
| 159 | MP0003567_abnormal_fetal_cardiomyocyte | 0.47912998 |
| 160 | MP0004484_altered_response_of | 0.47736494 |
| 161 | MP0005452_abnormal_adipose_tissue | 0.47489265 |
| 162 | MP0002796_impaired_skin_barrier | 0.46406444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.13514559 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.97795085 |
| 3 | Xanthomatosis (HP:0000991) | 4.87275082 |
| 4 | Hypoglycemic coma (HP:0001325) | 4.69036041 |
| 5 | Hyperglycinuria (HP:0003108) | 4.63164135 |
| 6 | Hyperammonemia (HP:0001987) | 4.62778325 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.60223019 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.47749966 |
| 9 | Ketosis (HP:0001946) | 4.47163034 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.24744333 |
| 11 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.24744333 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.17113851 |
| 13 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.02913278 |
| 14 | Ketoacidosis (HP:0001993) | 4.01315853 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.95449437 |
| 16 | Hyperglycinemia (HP:0002154) | 3.91899843 |
| 17 | Myoglobinuria (HP:0002913) | 3.84719515 |
| 18 | Complement deficiency (HP:0004431) | 3.83117451 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.82099309 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.77295389 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 3.61750676 |
| 22 | Epidermoid cyst (HP:0200040) | 3.55482209 |
| 23 | Distal lower limb amyotrophy (HP:0008944) | 3.54480317 |
| 24 | Hyperacusis (HP:0010780) | 3.51489533 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.47504115 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.47231154 |
| 27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.39462532 |
| 28 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.36266638 |
| 29 | Dicarboxylic aciduria (HP:0003215) | 3.36266638 |
| 30 | Distal lower limb muscle weakness (HP:0009053) | 3.34966777 |
| 31 | Sudden death (HP:0001699) | 3.25886365 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.25487280 |
| 33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.19766617 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.10383963 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.05636431 |
| 36 | Achilles tendon contracture (HP:0001771) | 3.00900166 |
| 37 | Myopathic facies (HP:0002058) | 3.00578941 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 2.94072723 |
| 39 | Skin nodule (HP:0200036) | 2.91967176 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 2.90226456 |
| 41 | Ulnar bowing (HP:0003031) | 2.84624671 |
| 42 | Hypercholesterolemia (HP:0003124) | 2.80002477 |
| 43 | Abnormality of complement system (HP:0005339) | 2.79046573 |
| 44 | Exercise-induced myalgia (HP:0003738) | 2.78152908 |
| 45 | Gout (HP:0001997) | 2.74375928 |
| 46 | Metabolic acidosis (HP:0001942) | 2.73970456 |
| 47 | Ventricular tachycardia (HP:0004756) | 2.73559995 |
| 48 | Abnormality of methionine metabolism (HP:0010901) | 2.73459087 |
| 49 | Broad face (HP:0000283) | 2.72550375 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 2.71954612 |
| 51 | Exercise-induced muscle cramps (HP:0003710) | 2.71301858 |
| 52 | Progressive muscle weakness (HP:0003323) | 2.69697597 |
| 53 | Joint hemorrhage (HP:0005261) | 2.69001998 |
| 54 | Dysmetric saccades (HP:0000641) | 2.67576639 |
| 55 | Increased connective tissue (HP:0009025) | 2.66902204 |
| 56 | Myocardial infarction (HP:0001658) | 2.65071992 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.61414153 |
| 58 | Abnormality of purine metabolism (HP:0004352) | 2.57590022 |
| 59 | Hyporeflexia of lower limbs (HP:0002600) | 2.52778727 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.52161300 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.52082643 |
| 62 | Fat malabsorption (HP:0002630) | 2.50304624 |
| 63 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.50301773 |
| 64 | Flat acetabular roof (HP:0003180) | 2.48520087 |
| 65 | Muscle fiber inclusion bodies (HP:0100299) | 2.45966613 |
| 66 | Cholelithiasis (HP:0001081) | 2.44925034 |
| 67 | Lethargy (HP:0001254) | 2.44312283 |
| 68 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.43860138 |
| 69 | Hyperbilirubinemia (HP:0002904) | 2.42835555 |
| 70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.42198480 |
| 71 | Lower limb amyotrophy (HP:0007210) | 2.41964631 |
| 72 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.41303855 |
| 73 | Hemorrhage of the eye (HP:0011885) | 2.40880429 |
| 74 | Type 1 muscle fiber predominance (HP:0003803) | 2.38756299 |
| 75 | Cerebral edema (HP:0002181) | 2.36136111 |
| 76 | Difficulty climbing stairs (HP:0003551) | 2.36070431 |
| 77 | Late onset (HP:0003584) | 2.35801591 |
| 78 | Atrioventricular block (HP:0001678) | 2.34810755 |
| 79 | Palpitations (HP:0001962) | 2.33907023 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.33666060 |
| 81 | Delayed CNS myelination (HP:0002188) | 2.31748044 |
| 82 | Trismus (HP:0000211) | 2.31650113 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 2.30956785 |
| 84 | Hepatocellular carcinoma (HP:0001402) | 2.30765809 |
| 85 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.29220064 |
| 86 | Muscle fiber splitting (HP:0003555) | 2.28695868 |
| 87 | Lipoatrophy (HP:0100578) | 2.28668701 |
| 88 | Nemaline bodies (HP:0003798) | 2.27530461 |
| 89 | Round ear (HP:0100830) | 2.27211123 |
| 90 | Nausea (HP:0002018) | 2.27130572 |
| 91 | Proximal tubulopathy (HP:0000114) | 2.25537541 |
| 92 | Cerebral aneurysm (HP:0004944) | 2.24202834 |
| 93 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24066537 |
| 94 | Upper limb amyotrophy (HP:0009129) | 2.21929804 |
| 95 | Distal upper limb amyotrophy (HP:0007149) | 2.21929804 |
| 96 | Hyperglycemia (HP:0003074) | 2.21212153 |
| 97 | Neonatal onset (HP:0003623) | 2.20007314 |
| 98 | Asymmetric septal hypertrophy (HP:0001670) | 2.19586840 |
| 99 | Abnormal cartilage morphology (HP:0002763) | 2.18909125 |
| 100 | Ragged-red muscle fibers (HP:0003200) | 2.18413252 |
| 101 | Advanced eruption of teeth (HP:0006288) | 2.17086728 |
| 102 | Spastic diplegia (HP:0001264) | 2.16676726 |
| 103 | Vertebral compression fractures (HP:0002953) | 2.13983897 |
| 104 | Back pain (HP:0003418) | 2.13467339 |
| 105 | Increased purine levels (HP:0004368) | 2.11005275 |
| 106 | Hyperuricemia (HP:0002149) | 2.11005275 |
| 107 | Vomiting (HP:0002013) | 2.09730586 |
| 108 | Stridor (HP:0010307) | 2.09729005 |
| 109 | Lymphangioma (HP:0100764) | 2.09552971 |
| 110 | Protrusio acetabuli (HP:0003179) | 2.06141761 |
| 111 | Abnormality of proline metabolism (HP:0010907) | 2.04340566 |
| 112 | Hydroxyprolinuria (HP:0003080) | 2.04340566 |
| 113 | Hypertriglyceridemia (HP:0002155) | 2.04132545 |
| 114 | Thin bony cortex (HP:0002753) | 2.04095159 |
| 115 | Reticulocytosis (HP:0001923) | 2.04008632 |
| 116 | Asymmetry of the thorax (HP:0001555) | 2.03469474 |
| 117 | Difficulty running (HP:0009046) | 2.01667699 |
| 118 | Abnormality of the salivary glands (HP:0010286) | 2.01081844 |
| 119 | Obstructive sleep apnea (HP:0002870) | 2.00764144 |
| 120 | Dilated cardiomyopathy (HP:0001644) | 1.99968488 |
| 121 | Increased muscle lipid content (HP:0009058) | 1.99927046 |
| 122 | Spinal rigidity (HP:0003306) | 1.98257591 |
| 123 | Premature rupture of membranes (HP:0001788) | 1.97477227 |
| 124 | Insomnia (HP:0100785) | 1.96944897 |
| 125 | EMG: myopathic abnormalities (HP:0003458) | 1.96198809 |
| 126 | Bulbar palsy (HP:0001283) | 1.95296799 |
| 127 | Esophageal varix (HP:0002040) | 1.95289751 |
| 128 | Conjunctival hamartoma (HP:0100780) | 1.92789961 |
| 129 | Abnormality of the Achilles tendon (HP:0005109) | 1.92350333 |
| 130 | Heart block (HP:0012722) | 1.91670965 |
| 131 | Calf muscle hypertrophy (HP:0008981) | 1.90360873 |
| 132 | Bundle branch block (HP:0011710) | 1.89755398 |
| 133 | Progressive external ophthalmoplegia (HP:0000590) | 1.89295639 |
| 134 | Ventricular arrhythmia (HP:0004308) | 1.88312946 |
| 135 | Disproportionate tall stature (HP:0001519) | 1.88095119 |
| 136 | Conjugated hyperbilirubinemia (HP:0002908) | 1.87506333 |
| 137 | Sensorimotor neuropathy (HP:0007141) | 1.84701179 |
| 138 | Atrial fibrillation (HP:0005110) | 1.84686745 |
| 139 | Abnormal gallbladder physiology (HP:0012438) | 1.84208083 |
| 140 | Cholecystitis (HP:0001082) | 1.84208083 |
| 141 | Generalized amyotrophy (HP:0003700) | 1.84147173 |
| 142 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.84044802 |
| 143 | Long palpebral fissure (HP:0000637) | 1.83951853 |
| 144 | Fragile skin (HP:0001030) | 1.83790764 |
| 145 | Abnormality of the thoracic spine (HP:0100711) | 1.83551819 |
| 146 | Pancreatitis (HP:0001733) | 1.82640579 |
| 147 | Multiple enchondromatosis (HP:0005701) | 1.82523852 |
| 148 | Hepatic necrosis (HP:0002605) | 1.81701075 |
| 149 | Ankyloglossia (HP:0010296) | 1.76863838 |
| 150 | Foot dorsiflexor weakness (HP:0009027) | 1.74287730 |
| 151 | Deviation of the thumb (HP:0009603) | 1.72968654 |
| 152 | Short nail (HP:0001799) | 1.71854706 |
| 153 | Selective tooth agenesis (HP:0001592) | 1.71459521 |
| 154 | Sparse lateral eyebrow (HP:0005338) | 1.70550415 |
| 155 | Neck muscle weakness (HP:0000467) | 1.70095041 |
| 156 | Acanthosis nigricans (HP:0000956) | 1.69463515 |
| 157 | Elbow flexion contracture (HP:0002987) | 1.66945223 |
| 158 | Muscle stiffness (HP:0003552) | 1.64405487 |
| 159 | Septate vagina (HP:0001153) | 1.63698378 |
| 160 | Easy fatigability (HP:0003388) | 1.63522632 |
| 161 | Abnormality of glycolysis (HP:0004366) | 1.63195381 |
| 162 | Abnormality of the calcaneus (HP:0008364) | 1.62901433 |
| 163 | Shallow orbits (HP:0000586) | 1.61803979 |
| 164 | Ridged nail (HP:0001807) | 1.60593440 |
| 165 | Natal tooth (HP:0000695) | 1.60272105 |
| 166 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.59726814 |
| 167 | Cerebral inclusion bodies (HP:0100314) | 1.58086572 |
| 168 | Neonatal death (HP:0003811) | 1.58028595 |
| 169 | Hyperparathyroidism (HP:0000843) | 1.56671632 |
| 170 | Metaphyseal cupping (HP:0003021) | 1.56487613 |
| 171 | Proximal placement of thumb (HP:0009623) | 1.56450720 |
| 172 | Termporal pattern (HP:0011008) | 1.55510865 |
| 173 | Insidious onset (HP:0003587) | 1.55510865 |
| 174 | Abnormality of the foot musculature (HP:0001436) | 1.55432916 |
| 175 | Abnormality of carpal bone ossification (HP:0006257) | 1.54035405 |
| 176 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.53734325 |
| 177 | Osteolytic defects of the hand bones (HP:0009699) | 1.53734325 |
| 178 | Abnormality of the fingertips (HP:0001211) | 1.53573148 |
| 179 | Abnormality of the tricuspid valve (HP:0001702) | 1.53272411 |
| 180 | Diaphragmatic weakness (HP:0009113) | 1.52180882 |
| 181 | Ulnar deviation of the wrist (HP:0003049) | 1.51521734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.95765418 |
| 2 | BCKDK | 4.90111934 |
| 3 | PKN2 | 4.24178659 |
| 4 | SMG1 | 4.16043602 |
| 5 | SIK1 | 3.33734350 |
| 6 | TTN | 3.01303138 |
| 7 | IRAK3 | 2.98589291 |
| 8 | ERN1 | 2.87255550 |
| 9 | PRPF4B | 2.77611590 |
| 10 | PDK4 | 2.73929950 |
| 11 | PDK3 | 2.73929950 |
| 12 | EPHA2 | 2.47130365 |
| 13 | FGFR4 | 2.41076091 |
| 14 | NME2 | 2.19581988 |
| 15 | LMTK2 | 2.17865885 |
| 16 | NEK1 | 2.06648292 |
| 17 | CAMK1D | 1.91474939 |
| 18 | RIPK1 | 1.79159498 |
| 19 | INSRR | 1.62655396 |
| 20 | OBSCN | 1.60355649 |
| 21 | MAP3K10 | 1.60115428 |
| 22 | EEF2K | 1.58492728 |
| 23 | PTK6 | 1.51301614 |
| 24 | FLT3 | 1.49034234 |
| 25 | MAP3K7 | 1.46754236 |
| 26 | PHKG2 | 1.43131685 |
| 27 | PHKG1 | 1.43131685 |
| 28 | MAP2K3 | 1.41981968 |
| 29 | PDK2 | 1.37141755 |
| 30 | LATS1 | 1.34100807 |
| 31 | RPS6KB2 | 1.28185854 |
| 32 | CAMK1G | 1.28151380 |
| 33 | MAPK11 | 1.24786292 |
| 34 | PRKAA2 | 1.19907852 |
| 35 | ICK | 1.19847200 |
| 36 | MTOR | 1.09485031 |
| 37 | CDK12 | 1.09055002 |
| 38 | MYLK | 1.06132810 |
| 39 | PDGFRA | 1.05981123 |
| 40 | PAK4 | 1.05771577 |
| 41 | PRKAA1 | 1.03369725 |
| 42 | MAP3K3 | 1.01717684 |
| 43 | ARAF | 1.00984347 |
| 44 | MST1R | 0.99516740 |
| 45 | PINK1 | 0.98886009 |
| 46 | MAP3K13 | 0.95105874 |
| 47 | CDK4 | 0.90025290 |
| 48 | CDK7 | 0.89199998 |
| 49 | MAP2K4 | 0.88003286 |
| 50 | DMPK | 0.87283332 |
| 51 | ERBB4 | 0.84097246 |
| 52 | TESK1 | 0.83903306 |
| 53 | PIM2 | 0.82597758 |
| 54 | MAP3K11 | 0.80387478 |
| 55 | JAK2 | 0.79459077 |
| 56 | TAOK1 | 0.75606433 |
| 57 | CDK6 | 0.73325101 |
| 58 | NEK9 | 0.72671159 |
| 59 | TIE1 | 0.72189932 |
| 60 | EPHB1 | 0.71554914 |
| 61 | PIK3CA | 0.70551888 |
| 62 | IRAK2 | 0.68687899 |
| 63 | RET | 0.67610429 |
| 64 | PRKD1 | 0.66256567 |
| 65 | TAOK3 | 0.65997113 |
| 66 | MAP3K5 | 0.65977841 |
| 67 | WNK4 | 0.65550382 |
| 68 | BMX | 0.65503524 |
| 69 | PDPK1 | 0.65412210 |
| 70 | BRAF | 0.64728232 |
| 71 | PRKD2 | 0.64212673 |
| 72 | STK38L | 0.63606540 |
| 73 | MAP3K9 | 0.63400634 |
| 74 | MARK2 | 0.63216399 |
| 75 | MAPKAPK3 | 0.62866073 |
| 76 | RPS6KA2 | 0.61876040 |
| 77 | KDR | 0.61384586 |
| 78 | JAK1 | 0.60920322 |
| 79 | MAPK12 | 0.60538063 |
| 80 | PRKACG | 0.60314439 |
| 81 | SGK3 | 0.59821006 |
| 82 | MAP2K2 | 0.59000594 |
| 83 | LRRK2 | 0.58629447 |
| 84 | PAK3 | 0.57167152 |
| 85 | PRKD3 | 0.57158213 |
| 86 | TESK2 | 0.56810275 |
| 87 | PDK1 | 0.56755176 |
| 88 | TYK2 | 0.56674405 |
| 89 | LATS2 | 0.55704875 |
| 90 | FGFR3 | 0.55547667 |
| 91 | STK38 | 0.53778281 |
| 92 | ALK | 0.50389307 |
| 93 | TGFBR2 | 0.50322314 |
| 94 | PAK2 | 0.49230084 |
| 95 | PIK3CG | 0.46967464 |
| 96 | CDK9 | 0.46876776 |
| 97 | MAP3K6 | 0.46833284 |
| 98 | PRKCH | 0.46828172 |
| 99 | MAP4K1 | 0.46026128 |
| 100 | AKT2 | 0.45554639 |
| 101 | CAMK4 | 0.45068490 |
| 102 | FGFR1 | 0.44950947 |
| 103 | GSK3A | 0.44480683 |
| 104 | AURKA | 0.43787697 |
| 105 | MAP3K14 | 0.43114376 |
| 106 | PRKG2 | 0.41581261 |
| 107 | MAP2K1 | 0.41220970 |
| 108 | ILK | 0.40948530 |
| 109 | CHEK1 | 0.40827608 |
| 110 | TBK1 | 0.39988085 |
| 111 | TRPM7 | 0.39725674 |
| 112 | NTRK1 | 0.39622851 |
| 113 | PRKCI | 0.39465795 |
| 114 | CDK8 | 0.39208847 |
| 115 | MET | 0.38897229 |
| 116 | CDC42BPA | 0.38590898 |
| 117 | PTK2 | 0.38081903 |
| 118 | ABL2 | 0.37276462 |
| 119 | KSR2 | 0.37161947 |
| 120 | TTK | 0.35203388 |
| 121 | SCYL2 | 0.35102737 |
| 122 | BUB1 | 0.35032741 |
| 123 | DDR2 | 0.34778902 |
| 124 | FGFR2 | 0.33527203 |
| 125 | DAPK2 | 0.33273383 |
| 126 | RPS6KA1 | 0.33083309 |
| 127 | BRD4 | 0.32888397 |
| 128 | GRK6 | 0.32789827 |
| 129 | TAOK2 | 0.32651328 |
| 130 | SIK2 | 0.32583249 |
| 131 | ERBB2 | 0.32344646 |
| 132 | HIPK2 | 0.31815255 |
| 133 | MAP3K1 | 0.31117673 |
| 134 | RPS6KA6 | 0.30905118 |
| 135 | MAP3K8 | 0.30805050 |
| 136 | TSSK6 | 0.30207895 |
| 137 | FRK | 0.29984103 |
| 138 | RPS6KL1 | 0.29534034 |
| 139 | RPS6KC1 | 0.29534034 |
| 140 | CDK2 | 0.29254747 |
| 141 | TYRO3 | 0.28918060 |
| 142 | MAPK10 | 0.28866561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.62431932 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.39845292 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.28508180 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.21502313 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.17789810 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.97962722 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.97548592 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.96563895 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.88627589 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79579961 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.68186634 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.53649477 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45511070 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.31827229 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.25273261 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.15623828 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.10269546 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 2.06597499 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.96886297 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.84851549 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.83162751 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79561945 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72845147 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71373757 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.68077330 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.66258086 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65270222 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44583663 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39028326 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38758408 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.37283958 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.35921084 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.32542117 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30753667 |
| 35 | Lysine degradation_Homo sapiens_hsa00310 | 1.30496649 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.29958313 |
| 37 | Thyroid cancer_Homo sapiens_hsa05216 | 1.29595690 |
| 38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.27986292 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26980305 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.26851904 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26582797 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24784907 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.24424232 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.24392302 |
| 45 | DNA replication_Homo sapiens_hsa03030 | 1.23091038 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20745764 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20257201 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.19810273 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17522605 |
| 50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16961884 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.15230853 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15190442 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11801832 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10539273 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09106995 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07839784 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04669425 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.02961536 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01194376 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.98393803 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.97342274 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96983800 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96530326 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.96393414 |
| 65 | Glioma_Homo sapiens_hsa05214 | 0.92827748 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89556967 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89343623 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.83812188 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80870204 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79252093 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79036034 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78246196 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.77913803 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.77549601 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75007985 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.74527602 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73971561 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73850451 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70676009 |
| 80 | Prostate cancer_Homo sapiens_hsa05215 | 0.69694108 |
| 81 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69274540 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.67917083 |
| 83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66854000 |
| 84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66795461 |
| 85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66238668 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63104714 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59993924 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59545081 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58710406 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58388876 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.58372806 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58185908 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57972331 |
| 94 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57933927 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.57677111 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52714480 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52535417 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.52427912 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52156006 |
| 100 | Cell cycle_Homo sapiens_hsa04110 | 0.51755081 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49836047 |
| 102 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49746821 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.48548453 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48237028 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47235526 |
| 106 | Base excision repair_Homo sapiens_hsa03410 | 0.46500242 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44914156 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44484461 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.44085320 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41884465 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41631952 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40497509 |
| 113 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40085718 |
| 114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39961476 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38871731 |
| 116 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38257636 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37463146 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36639566 |
| 119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34918850 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.32982767 |
| 121 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30424747 |
| 122 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.26295276 |
| 123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24488519 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18131792 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17374078 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17264962 |
| 127 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16054721 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13395765 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.11765418 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.08874521 |
| 131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.08150124 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.04331840 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01334269 |
| 134 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00897075 |
| 135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0995001 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | -0.0895413 |
| 137 | Bladder cancer_Homo sapiens_hsa05219 | -0.0882181 |
| 138 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.0832032 |
| 139 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0707699 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | -0.0681108 |
| 141 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0394275 |
| 142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.0377516 |
| 143 | Viral myocarditis_Homo sapiens_hsa05416 | -0.0178943 |
| 144 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0061154 |

